LAMP1 and colon adenocarcinoma: In this study, for the first time, we developed a novel 89Zr-DFO-mAb PET tracer targeting LAMP-1 and demonstrated its potential as an imaging biomarker for the non-invasive detection of breast and colon adenocarcinomas.